Trial Profile
ThE SoF-Trial (SoFT) - The Effect of Sevelamer on FGF23 Trial - A clinical trial assessing the quantitative effect of phosphate binding therapy on FGF23.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2017
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms SOFT
- 29 Jul 2014 New trial record